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Abstract Femoral head necrosis (FHN) is a progressive
pathology due to the failure of blood supply to the proximal
femoral epiphysis, with consequent necrosis of the sub-
chondral bone and collapse of the articular cartilage and
loss of congruity between the head and the acetabulum.
Borrowing the biological and mechanical principles from
the vascularized fibular graft technique for the femoral
neck, the tantalum screws have been introduced. They
show an extraordinary porosity, osteoconductivity, bio-
compatibility and very good osteoinductivity. Vitreous
tantalum can be processed to take the form of a screw, with
a round medial extremity and a 25 mm threaded lateral
extremity that can be inserted into the neck of the femur,
thereby supporting the articular cartilage, stimulating the
repair process, interrupting the interface between necrotic
and healthy tissue and favoring local vascularization. We
have drawn up a treatment protocol for early-stage FHN,
based on the insertion of a tantalum screw into the femoral
neck. The implant has a cylindrical shape, with a 10 mm
diameter in the smooth part and 15 mm in the threaded
part. It is available in different sizes from 70 to 130 mm,
with 5 mm increments. The aim of the study is to describe
the clinical and instrumental results of the tantalum screw
for FHN. From June 2004 to June 2006 we performed 15
implants. The tantalum screw was inserted with an incision
on the trochanteric region with traction and under X-ray
control. For the clinical evaluation of the hip, we used the
Harris hip score (HHS). For diagnosis and staging we used
standard X-rays in two views and/or MRI, using the
Steinberg classification (J Bone Joint Surg Br 77:34–41,
1995) and CT. In all cases, the osteonecrosis extended to
not more than 30% of the joint surface and the cartilage
was intact with no collapse. To assess the results, we
compared the pre-operative and the post-operative HHS,
calculated the percentage differences between the two. We
then compared X-rays, CT scans and MRI before and some
time after the operation to assess whether the problem had
been addressed, taking into account the intracancellous
edema and the possible extension of necrosis. After an
average follow-up period of 15.43 ± 5.41 months, ten
implants (seven patients out of ten) were examined and all
but one patient showed a marked improvement in HHS (the
average increase was 127.9%), with no further progression
of the disease. We believe that this procedure can be
suitable for young patients with limited first or second
stage osteonecrosis. The objective for the foreseeable
future is to resolve the pain, improve the quality of life and
prevent or at least postpone arthroplasty.
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Introduction
Femoral head necrosis (FHN) is a progressive pathology,
either primary or secondary to systemic or localized dis-
eases whose common feature is the failure of blood supply
to the proximal femoral epiphysis, with consequent
necrosis of the sub-chondral bone and collapse of the
articular cartilage and loss of congruity between the head
and the acetabulum.
This pathology is also known as bone coronary disease.
Indeed, the anatomical areas of the femoral epiphysis most
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often involved (the upper and the anterolateral ones) are
characterized by a reduced vascular supply and a forced
retrograde flow towards the trochanteric region, because of
the extensive articular cartilage [1].
The treatment of this pathology, characterized by pain
and limited function which are closely correlated with the
stage of the disease, depends on the patient’s age, type of
occupation, etiology, degree of articular function, onset and
characteristics of pain, the possibile extension or bilateral
nature of the disease and general metabolic status.
Based on these considerations and above all on the stage
of the disease, there are three possible treatment options:
non-invasive treatment (non weight-bearing; joint mobility
with passive and active exercises, magnetic field therapy,
hyperbaric therapy); conservative surgical treatment
(cervico-cephalic perforations; core decompression; auto-
plastic grafts; arthrodiatasis; osteotomy); replacement
surgery (endoprosthesis; arthroplasty) [2].
When the aim is to resolve the pain and stop the evo-
lution of the disease and hence prevent arthritic
degenerative changes and avoid prosthesis, early treatment
is necessary in order to stop cartilage stripping and the
collapse of the articular surface.
The gold standard of conservative treatment is repre-
sented by early diagnosis, subchondral bone decompression,
removal of necrotic tissue, support of joint surface and
activation of the repair processes. This objective can be
achieved by means of different techniques, which can be
more or less invasive and more or less complex.
Borrowing the biological and mechanical principles
from the vascularized fibular graft technique for the fem-
oral neck, the tantalum screws have been introduced.
Tantalum is a highly biocompatible metal, with very
good osteoinductive properties. Thanks to a special
industrial process, this metal can be made to emulate the
trabecular structure of cancellous bone. After a special
treatment tantalum, now turned into Vitreous Tantalum
(98% tantalum, 2% vitreous carbon), acquires a structure
characterized by an extraordinary porosity involving up to
80% of its volume, with evenly distributed 550 lm inter-
connected pores. These characteristics make tantalum a
highly osteoconductive material.
Vitreous tantalum can be processed to take the form of a
screw, with a round medial extremity and a 25 mm
threaded lateral extremity that can be inserted into the neck
of the femur, thereby supporting the articular cartilage,
stimulating the repair process, interrupting the interface
between necrotic and healthy tissue and favoring local
vascularization [6–11].
In the light of the above considerations we have drawn
up a treatment protocol for early-stage FHN, based on the
insertion of a tantalum screw into the femoral neck. This
implant, marketed in Italy by Zimmer Fracture
Management under the name of On Rode, was first laun-
ched in the US market in March 1998 and in the European
market on November 19, 2001.
The implant has a cylindrical shape, with a 10 mm
diameter in the smooth part and 15 mm in the threaded
part. It is available in different sizes from 70 mm to
130 mm, with 5 mm increments.
The aim of the study is to describe the clinical and
instrumental results of the tantalum screw for FHN.
Materials and methods
In order to analyze the possible utilization of the tantalum
screw in the femoral hip osteonecrosis, we have performed
an observational study, with prospective record of hip
scores and retrospective analysis of imaging studies. From
June 2004 to June 2006 we performed 15 implants: 5
monolateral (3 right, 2 left), 5 bilateral implants.
One implant was applied in a patient with post-traumatic
osteonecrosis; one in a patient with ulcerous rectocolitis;
five in kidney-transplanted patients; two in a patient with
cerebral neoplasia, three in HIV+ patients; three in patients
with idiopathic osteonecrosis (Table 1).
All ten patients, six males and four females, age range
28–69 years (mean age 42 ± 12 years) were symptomatic.
One patient with bilateral FHN had already received an
uncemented total hip prosthesis on the opposite side
(Tables 2, 3).
For the clinical evaluation of the hip we used the Harris
hip score (HHS), focusing on items related to quantification
of pain and functional deficit. For diagnosis and staging we
Table 1 The number of the implants and aetiology, stage of necrosis
and side NTF
No. of implants Etiology Stage Side
1 Post traumatic 2 sx
1 Ulcerative colitis 2 dx
2 Cerebral neoplasm 1 dx
2 sx
3 hiv+, hcv+ 2 dx
1 sx
1 sx
3 Idiopatic 1 dx
2 dx
2 sx
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used standard X-rays in two views, the MRI, using the
Steinberg classification [12, 13], and the CT. Five implants
were performed in the first-stage FHN, and ten in the sec-
ond-stage FHN. In all the cases, the osteonecrosis extended
to not more than 30% of the joint surface and the cartilage
was intact with no collapse. The Rx controls were per-
formed in the postoperative period and then after 3months.
Rx and RMI were performed after 12 and 24 months.
Traction and X-ray control were used to insert the tan-
talum screw. Through a straight incision on the lateral
aspect of the thigh, centered in the trochanteric region, it is
possible to reach the point between the trochanter and the
femoral diaphysis. Under X-ray control, a guide wire is
introduced into the cephalic area of necrosis in the head.
Then with incremental reamers a tunnel is created in the
femoral neck, up to a diameter of 10 mm. After measuring
the length, the implant is inserted. This will have to be well
introduced into the lateral cortex of the femur and properly
tapped, thanks to the threaded part of the implant.
To assess results we compared the pre-operative and the
post-operative HHS. We then compared X-rays and MRI
before and after the operation to assess whether the prob-
lem had been addressed, taking into account the
intracancellous edema and the possibile extension of
necrosis.
Results
The mean surgical time was of 25 min. No intra-operative
and immediate post-operative complications were recorded.
Due to trauma, two patients sustained a sub-trochanteric
fracture 9–10 days after surgery (Case 5 and Case 9). Both
patients were operated on, to remove the implants and
apply a cephalic plate with screws. Fracture union was
finally achieved in both the patients, but necrosis is still
present.
A third implant (Case 6) was removed after 12 months
due to persistent pain and progress of necrosis. After
removing the implant a non-cemented HA-coated pros-
thesis was applied.
We have evaluated seven patients (ten implants). The
average follow-up period was 15.43 ± 5.41 months. All
the patients, but one (Case 6), showed a marked
improvement in HHS, with no further progression of the
disease at the MRI analysis (Table 4).
Discussion
The operative technique is simple, free from risks and
complications. The tantalum screw seems to produce
encouraging results, above all in reducing pain, improving
hip function and probably stopping the further progression
of the pathology. This surgical procedure accomplishes two
functions: by drilling and reaming up to the joint cartilage,
it is possibile to decompress the femoral epiphysis and
remove necrotic tissue; with the implant directed towards
Table 2 The surgery, date, age,
sex, the side and aetiology of
NTF
a Arthroprothesis on the right
side
b Hip fracture
No. Surname and name Data of surgery Age Sex Side Etiology
1 C.R. 15/06/2004 28 M dx Idiopatic
2 S.L. 21/10/2004 69 F bil Kidney trasplantation
3 B.L. 15/02/2005 28 M sx Post traumatic
4 B.L. 21/02/2005 41 F bil hiv+, hcv+
5 B.Gb 20/05/2005 37 M bil idiopatic
6 G.C.a 07/07/2005 42 M sx hiv+, hcv+
7 V.M. 18/10/2005 44 M dx Ulcerative colitis
8 D.R. 14/02/2006 50 F dx Kidney trasplantation
9 V.L.b 30/05/2006 50 M bil Kidney trasplantation
10 P.D. 16/05/2006 34 F bil Cerebral neoplasm
Mean 42
Standard deviation 12
Table 3 Stage of the NTF with Herris Hip Score before surgery
No. Surname and name Stage HHS before surgery
1 C.R. 1 42
2 S.L. 1–1 20
3 B.L. 2 68
4 B.L. 2–1 28
5 B.G. 2–2 40
6 G.C. 1 77
7 V.M. 2 48
8 D.R. 2 45
9 V.L. 2–2 38
10 P.D. 1–2 70
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the osteonecrotic site, it is possibile to initiate the repair
process and provide a mechanical support to the joint
surface, as weight bearing is allowed immediately after the
operation (Fig. 1). We cannot rule out that the standard
diameter of 10 mm in the smooth part and 15 mm in the
threaded part may somehow weaken the sub-trochanteric
Table 4 Harris Hip Score
before and after surgery
The positive or negative
variations and their percentages
are reported















1 C.R. Monolat. 15/06/2004 42 96 54 128.6 24
2 S.L. Bil. 21/10/2004 20 98 78 390.0 20
3 B.L. Mon. 15/02/2005 68 88 20 29.4 16
4 B.L. Bil. 21/02/2005 28 72 44 157.1 16
5 B.G. Bil. 20/05/2005 40 100 60 150.0 13
6 G.Ca. Monolat. 07/07/2005 77 31 –46 -59.7 11
7 V.M. Monolat. 18/10/2005 48 96 48 100.0 8
Mean 46.1 83.0 127.9 15.43
Standard Deviation 20.4 24.8 138.9 5.41
Fig. 1 a Case No.1, C. R.
Female 28-years-old. Right
femoral head necrosis,
idiopathic, stage 1. HHS before
surgery: 42. b C. R. Female 28-
years-old. Post-surgery checkup
after 24 months. HHS after
surgery: 96 (+54)
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region, thereby favoring fractures at this level. In the two
cases where this actually happened, the site had been
subjected to trauma, but the eccentric implant in the fem-
oral shaft may have weakened one of the two cortices at the
entry site of the screw, thus favoring the fracture. This
problem could be addressed with smaller diameter screws
Tantalum, in its trabecular form, combines strong
mechanical resistance with high biocompatibility and os-
teoconductive and osteoinductive properties. For these
reasons, it could be the right material for treating this
pathology, which requires both a mechanical and a bio-
logical approach. We think that the tantalum screw could
be indicated only in the first-and-second stage FHN,
involving not more than 30% of the joint surface, indeed
it shows to provide a mechanical support for the joint
surface and favor post-necrotic repair processes, at the
same time not ruling out a late prosthesis in case of
failure (Fig. 2).
The reasons for the failure of implant Nr.6 are related to
underestimation of the extent of necrosis before surgery.
One single tantalum screw is unable to address not only
extensive necrosis, but also first or second stage multifocal
FHN, as shown. It should also be noted that the effects of
the implant may be severely limited by the etiology of
osteonecrosis, which may often be the consequence of a
systemic pathological condition that will continue to pro-
gress even after treatment. We think that the rather high
failure rate of the conservative surgical treatments could be
partly due to the currently used classifications, based solely
on X-rays that fail to identify FHN in its initial stages.
Image diagnosis, in particular MRI and CT, can solve this
problem. MRI can highlight early deterioration of the in-
tracephalic circulation, whatever be its nature (intravasal or
extravasal). CT makes it possible to accurately assess the
extent of necrosis and mark the borders between the
necrotic area and the healthy tissue [3–5].
Fig. 2 a Case No.6, G.C.
Female 42-years-old. Biltaral
femoral head necrosis. On the
right side multifocal; on the left
side stage 1 in HIV+/HCV+-
patient. On the right side, due to
the wide necrosis extension, we
implanted a uncemented
arthroprothesis; on the left side,
the necrosis was stage 1, so we
implanted tantalum screw. HHS
beforse surgery on the left side
was 77. b G.C. Female 42-
years-old. Post-surgery checkup
after 11 months. RX-images
and MRI show an osteonecrosis
evolution with collapse of the
articular cartilage. HHS after
surgery was 31 (-46)
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In conclusion, in the light of the above considerations
we believe that this procedure can be suitable for young
patients with limited first-or-second stage osteonecrosis.
This treatment could be preferred to the non-invasive
treatment because this one requires long periods of non-
weight bearing that patients may not easily accept. Besides,
only if the non-invasive treatment is started really early it
can contrast the evolution of the disease (4 years after
diagnosis necrosis tends to extend to 80% of the joint
surface).
The objective for the foreseeable future is to resolve
pain, improve the quality of life and prevent or at least
postpone arthroplasty, though it may in future be possible
to repair the necrotic tissue with molecular biology.
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